A Biomarker Screening Protocol for Participants With Solid Tumors

Clinical trial NCT05891197 · TERMINATED

Trial details

NCT number: NCT05891197
Sponsor: Lyell Immunopharma, Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Triple Negative Breast Cancer Non-small Cell Lung Cancer Non Small Cell Lung Cancer Non Small Cell Lung Cancer Metastatic Non-Small Cell Carcinoma of Lung, TNM Stage 4 Advanced Breast Cancer Advanced Lung Carcinoma NSCLC NSCLC, Recurrent NSCLC Stage IV Relapsed Cancer Relapse/Recurrence

Start date: 2023-05-19
Primary completion: 2025-02-05
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.